摘要
目的探讨肝星状细胞(HSC)对肝癌细胞(HCC)恶性生物学行为的影响及其相关机制。方法分别培养SMMC-7721肝癌细胞、Hep G2肝癌细胞和LX-2 HSC,采用LX-2 HSC条件培养基(LX2-CM)、丝裂原激活蛋白激酶(MAPK)特异性抑制剂U0126处理肝癌细胞,TranswellTM小室检测肝癌细胞的侵袭和迁移能力,CCK-8法检测细胞的增殖情况,实时定量PCR和Western blot法分别检测两种肝癌细胞磷酸化的胞外信号调节激酶1/2(p-ERK1/2)、ERK1/2、c-Myc、波形蛋白(vimentin)、上皮钙黏素(E-cadherin)的mRNA和蛋白水平。结果 LX2-CM能促进SMMC-7721细胞和Hep G2细胞的增殖、侵袭和迁移,其作用可被U0126阻断。LX2-CM可以上调p-ERK1/2、c-Myc、vimentin的水平,下调E-cadherin的水平;U0126处理细胞后,p-ERK1/2、c-Myc、vimentin的水平显著降低,E-cadherin水平明显升高。结论 LX2-CM能通过ERK1/2通路激活c-Myc,促进肝癌细胞的增殖、侵袭和迁移,并诱导上皮间质转化。
Objective To investigate the influence of hepatic stellate cells( HSCs) on malignant biological behavior of hepatoma cells and related mechanisms. Methods Human hepatoma cell lines SMMC-7721 and Hep G2,and hepatic stellate cell line LX-2 were cultured separately. HSC conditioned medium( LX2-CM),MAPK specific inhibitor U0126 were used to treat hepatoma cells,separately or together. The invasion and migration abilities of hepatoma cells were detected by TranswellTMassay,and cell proliferation was analyzed by CCK-8 assay. The mRNA and protein expression levels of p-ERK1 /2,ERK1 /2,c-Myc,vimentin and E-cadherin were determined by real-time PCR and Western blot analysis,respectively.Results LX2-CM promoted the proliferation,invasion and migration of SMMC-7721 and Hep G2 cells,and these effects were inhibited by U0126. LX2-CM up-regulated the expression levels of p-ERK1 /2,c-Myc,vimentin and down-regulated the expression level of E-cadherin. Conversely,after U0126 treatment,the expression levels of p-ERK1 /2,c-Myc and vimentin decreased significantly,while E-cadherin expression level increased. Conclusion LX2-CM could activate c-Myc via ERK1 /2signaling pathway in hepatoma cells,and consequently promote cell proliferation,invasion and migration,and also induce epithelial-mesenchymal transition.
作者
谢雨潇
廖锐
潘龙
范凯
彭聪
杜成友
XIE Yuxiao LIAO Rui PAN Long FAN Kai PENG Cong DU Chengyou(Department of Hepatobiliary Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China)
出处
《细胞与分子免疫学杂志》
CAS
CSCD
北大核心
2017年第2期210-214,219,共6页
Chinese Journal of Cellular and Molecular Immunology
基金
国家临床重点专科建设项目([2012]649号)
国家自然科学基金(81301656)
重庆市渝中区科委基础与前沿研究计划项目(20140109)